๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

Sulfadoxine-pyrimethamine for the treatment of malaria

โœ Scribed by Nicholas J. White


Publisher
Elsevier Science
Year
1991
Tongue
English
Weight
251 KB
Volume
85
Category
Article
ISSN
0035-9203

No coin nor oath required. For personal study only.


๐Ÿ“œ SIMILAR VOLUMES


Sulfadoxine-pyrimethamine for the treatm
โœ P. Deloron; J. Mayombo; A. Le Cardinal; J. Mezui-Me-Ndong; C. Bruzi-Baert; F. Le ๐Ÿ“‚ Article ๐Ÿ“… 2000 ๐Ÿ› Elsevier Science ๐ŸŒ English โš– 431 KB

Chloroquine can no longer be recommended as the first-line treatment for falciparum malaria in several parts of Africa, given the increasing resistance of Plasmodium falcipanrm to this drug. The sulfadoxinepyrimethamine combination (SP) is obviously an alternative candidate, that has already been se

A randomized safety and tolerability tri
โœ J.F. Doherty; A.D. Sadiq; L. Bayo; A. Alloueche; P. Olliaro; P. Milligan; L. von ๐Ÿ“‚ Article ๐Ÿ“… 1999 ๐Ÿ› Elsevier Science ๐ŸŒ English โš– 474 KB

Artemisinin derivatives, such as artesunate, have a short half-life and very rapid anti-malarial activity. Theoretically, using such agents in conjunction with well-established anti-malarial drugs such as sulfadoxine-pyrimethamine may reduce the rate of drug resistance. Such a combination has not pr

A comparison of amodiaquine and sulfadox
โœ J. van Dillen; M. Custers; A. Wensink; B. Wouters; T. van Voorthuizen; W. Voorn; ๐Ÿ“‚ Article ๐Ÿ“… 1999 ๐Ÿ› Elsevier Science ๐ŸŒ English โš– 482 KB

A randomized 14-day study in vivo compared the response of Plasmodium falciparum malaria to amodiaquine (35 mg/kg) and sulfadoxine-pyrimethamine (sulfadoxine, 25 mg/kg) in symptomatic outpatients at 2 sites in northern and western Kenya during 1993. Of the 239 patients recruited, 181 (76%) completed